FDA Drugs (New Approvals & NDA)Original article
Communicating Drug Interaction and QTc Information in the U.S. Prescribing Information - 09/23/2026
RegulatoryNeutral
AI Analysis
Summary
FDA is hosting a webinar on September 23, 2026 to discuss draft guidance on drug interaction information and QTc information in prescription drug labeling.
Importance:2/10
Sentiment:
0.00
FDA guidancedrug interactionQTc informationprescribing informationwebinar
Related Companies
Read the original article
Published by FDA Drugs (New Approvals & NDA) on September 14, 2026 3:01 PM